But it doesn't provide justice here for the taxpayers, and I would ask the taxpayers what they think.
Editor's note · Context
Steve King expresses concern that the interests of pharmaceutical companies are being prioritized over taxpayer interests.
Share
More from Steve King
I will conclude my remarks, and I yield back the balance of my time. ____________________
I was unable to vote on December 20, 2020 and December 21, 2020 due to not being in DC. Had I been present, I would have voted as follows: ``no'' on rollcall No. 248; ``no'' on rollcall No. 249; ``no'' on rollcall No. 250; and ``no'' on…
I have an amendment at the desk made in order by the rule. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: Page 135, beginning on line 3, strike ``date on which the major disaster or…
I appreciate the privilege to be recognized to address you here on the floor of the House of Representatives. Having listened to the gentleman ahead of me, Mr. Louie Gohmert and some of the discussion that he had, I would pick up with the…





